Meierhofer, David Mass Spectrometry Facility (Head: David Meierhofer), Scientific Service (Head: Christoph Krukenkamp), Max Planck Institute for Molecular Genetics, Max Planck Society;
(No access)
Hudert, C. A., Adams, L. A., Alisi, A., Anstee, Q. M., Crudele, A., Draijer, L. G., et al. (2022). Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. Hepatology Communications, 2022: 1955. doi:10.1002/hep4.1955.